Cypress Growth Capital provides royalty-based growth capital as an alternative to equity funding for companies. The firm offers non-dilutive funding in exchange for a fixed percentage of the client company's future monthly revenues, with the obligation ending when a predetermined cap is reached.

Cypress Growth Capital

For an entrepreneur considering growth funding, Cypress G﻿rowth Capital provides an innovative alternative to equity and traditional debt. Our firm invests in emerging companies using a royalty-based approach that preserves an entrepreneur's equity and control.

With investments in more than 55 premier software and technology-enabled services companies since 2010, Cypress offers a flexible, patient form of debt capital that is well-suited to the unique financing needs of fast-growing companies.

Offering more than just capital, our partners have extensive operating and entrepreneurial experience bringing useful, practical assistance to our portfolio companies. More than 90% of the companies we fund and support achieve their desired outcome--typically a large, follow-on growth equity round, a majority recapitalization, or a strategic sale.

Altitude Digital

zvelo

Greystone Technology

Rehearsal

Stackify

Dialexa

ClearVoice

Conductus

Tiempo Development

Cypress Growth Capital congratulates Bill Clerici, Greg Hart, Kevin Carney and the entire team at Charlotte-based Kingsmen Software on their successful exit to Sparq, a leading US-based provider of outsourced digital engineering for Fortune 1000 companies. Cypress first invested in Kingsmen in 2018 and this team of talented entrepreneurs created a company known for innovation, reliability, and trust. Kingsmen's deep expertise in FinTech and generative AI will bring significant value to Sparq and its clients. We are proud to have been their partner.

https://lnkd.in/dU8kkfZ6

We're Growing Our Team!

If you or someone in your network is seeking a career in venture capital focused on investing in emerging technology companies, please share the Research & Lead Generation Analyst opportunity below.

Congratulations to Matt Yagey and the team at Medchat on their new strategic partnership with Healthgrades. Healthgrades' market leadership as a patient search tool and Medchat’s HIPAA-compliant platform for connecting patients with healthcare professionals are a powerful combination. Cypress Growth Capital is excited about Medchat’s future and the potential of this partnership. 

Please read more about the partnership here: https://lnkd.in/gMGjAYK9

Bart Goodwin, Pat M., Ed Mello, Vik Thapar, Vincent Hsieh

#growthcapital #SaaS #Innovation #healthcaretech

🚀 New Episode Alert! 🎙️

In this episode of the Ignite Podcast, we sit down with Vince Hsieh, partner at Cypress Growth Capital. Vince shares his incredible journey from management consulting to entrepreneurship and now venture capital. Learn about the unique benefits of royalty-based financing and gain insights on scaling startups, building strong teams, and navigating the challenges of entrepreneurship. Don’t miss this episode packed with valuable lessons and advice for entrepreneurs and investors alike!

👂🎧 Watch or listen on your favorite network: https://buff.ly/3I86nww 

#Entrepreneurship #VentureCapital #StartupGrowth #TechInvesting #BusinessLeadership #IgnitePodcast #RoyaltyBasedFinancing #CypressGrowthCapital #IoTStartups #InvestmentStrategies

Metric
Company Name	Cypress Growth Capital
Symbol
MSH ID	COM:CYPRESSGROWTHCAPITAL
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Alternative Financing
Country	US
Stage
Employee Count	10
Website	cypressgrowthcapital.com
LinkedIn	cypress-growth-capital-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	884
Web Traffic Growth	-0.57
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CYPRESSGROWTHCAPITAL

Cypress Growth Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue